Search

Search Results
Results 17221 - 17230 of 18476 for breast cancer
  • Drug - 28 Jan 2025
    Consumer Medicine Information (CMI) about Onureg intended for persons living in Australia.
  • Drug - 23 Jan 2025
    Consumer Medicine Information (CMI) about Revlimid intended for persons living in Australia.
  • News - 22 Jan 2025
    People genetically susceptible to Huntington's disease often see their movement, mood, and cognition decline slowly over time.
  • Drug - 6 Jan 2025
    Consumer Medicine Information (CMI) about Alecensa intended for persons living in Australia.
  • News - 10 Dec 2024
    Findings indicate microplastics in blood are linked to inflammation and coagulation markers, underscoring the need for reduced exposure and further research.
  • Drug - 23 Oct 2024
    Consumer Medicine Information (CMI) about Mektovi intended for persons living in Australia.
  • Drug - 22 Oct 2024
    Consumer Medicine Information (CMI) about Tafinlar intended for persons living in Australia.
  • News - 18 Oct 2024
    Waymark, a public benefit company dedicated to improving access and quality of care in Medicaid, today published a peer-reviewed study in the New England Journal of Medicine (NEJM) Catalyst evaluating...
  • Drug - 15 Oct 2024
    Consumer Medicine Information (CMI) about Proquad intended for persons living in Australia.
  • Drug - 4 Oct 2024
    Consumer Medicine Information (CMI) about Lemtrada intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.